Company: INSP
Filing Date: 2025-11-03
Form Type: 10-Q
Source: 0001609550-25-000053
Chunk: 91

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-11-03
Form: 10-Q
Item: Part I, Item 8
Chunk 91
---
 under the ESPP— 14,185 3,492 4,728 Weighted average number of common shares outstanding — diluted29,600,223 30,633,789 29,938,246 30,566,395 Net income per share:Basic$0.34 $0.62 $0.32 $0.61 Diluted$0.34 $0.60 $0.31 $0.60 The following common stock-based awards were excluded from the computation of diluted net income per common share for the periods presented because including them would have been antidilutive:Three Months EndedNine Months EndedSeptember 30,September 30,2025202420252024Stock options1,417,098 1,465,714 1,433,667 1,519,841 Restricted stock units954,933 313,776 515,639 50,582 Shares issuable under the ESPP12,610 — 4,203 — Total2,384,641 1,779,490 1,953,509 1,570,423 

10. Related Party Transaction

In December 2023, we entered into an agreement with an entity controlled by our Chief Executive Officer (the "Entity"), pursuant to which we agreed to share the costs of a corporate suite at a sports and entertainment venue (the "Venue") (the “Suite”) (the “Cost Sharing Agreement”). In August 2023, the Entity entered into an agreement with the Venue, pursuant to which the Entity acquired certain rights to use the Suite for specified sporting and other events at the Venue through August 2026. Pursuant to this agreement, the Entity agreed to pay $0.2 million per year, with each year beginning September 1 and ending August 31, and the fee increasing by 5% for each succeeding year. Under the Cost Sharing Agreement, we will reimburse the Entity 50% of the cost of the Suite in exchange for the right to use the Suite for 50% of the specified events at the Venue through August 2026. We recognized expense of $0.1 million for the use of the suite in SG&A expense in our consolidated statements of operations and comprehensive income during each of the three months ended September 30, 2025 and 2024, respectively, and $0.3 million and $0.1 million during the nine months ended September